Taiwan Biomaterial Co., Ltd. (6649.TWO)
TWD 35.6
(3.34%)
TWD 35.6
(3.34%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 88.38 Million TWD | -0.57% |
| 2022 | 88.88 Million TWD | -32.09% |
| 2021 | 130.89 Million TWD | 26.56% |
| 2020 | 103.42 Million TWD | -24.03% |
| 2019 | 136.14 Million TWD | 1364.2% |
| 2018 | 9.29 Million TWD | -19.28% |
| 2017 | 11.51 Million TWD | 99.81% |
| 2016 | 5.76 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 76.73 Million TWD | -13.18% |
| 2024 Q2 | 73.45 Million TWD | -4.28% |
| 2023 FY | 88.38 Million TWD | -0.57% |
| 2023 Q4 | 88.38 Million TWD | 7.11% |
| 2023 Q1 | 84.29 Million TWD | -5.17% |
| 2023 Q2 | 93.46 Million TWD | 10.89% |
| 2023 Q3 | 82.52 Million TWD | -11.71% |
| 2022 Q2 | 103.51 Million TWD | 3.24% |
| 2022 FY | 88.88 Million TWD | -32.09% |
| 2022 Q4 | 88.88 Million TWD | -18.16% |
| 2022 Q3 | 108.6 Million TWD | 4.92% |
| 2022 Q1 | 100.26 Million TWD | -23.4% |
| 2021 Q4 | 130.89 Million TWD | 24.17% |
| 2021 FY | 130.89 Million TWD | 26.56% |
| 2021 Q3 | 105.41 Million TWD | 0.0% |
| 2020 FY | 103.42 Million TWD | -24.03% |
| 2019 FY | 136.14 Million TWD | 1364.2% |
| 2018 FY | 9.29 Million TWD | -19.28% |
| 2017 FY | 11.51 Million TWD | 99.81% |
| 2016 FY | 5.76 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Health & Life Co., Ltd. | 375.41 Million TWD | 76.457% |
| Hi-Clearance Inc. | 1.63 Billion TWD | 94.591% |
| Universal Vision Biotechnology Co., Ltd. | 1.78 Billion TWD | 95.056% |
| Radiant Innovation Inc. | 53.23 Million TWD | -66.023% |
| United Orthopedic Corporation | 2.82 Billion TWD | 96.869% |
| Ma Kuang Healthcare Holding Limited | 1.1 Billion TWD | 91.972% |
| Bioptik Technology Incorporation | 673.55 Million TWD | 86.878% |
| Arich Enterprise Co., Ltd. | 3.6 Billion TWD | 97.545% |
| MedFirst Healthcare Services, Inc. | 6.17 Billion TWD | 98.569% |
| AmCad BioMed Corporation | 34.69 Million TWD | -154.724% |
| S&S Healthcare Holding Ltd. | 209.24 Million TWD | 57.76% |
| AViTA Corporation | 350.79 Million TWD | 74.805% |
| Cowealth Medical Holding Co., Ltd. | 1.6 Billion TWD | 94.5% |
| Onyx Healthcare Inc. | 527.66 Million TWD | 83.25% |
| PlexBio Co., Ltd. | 92.26 Million TWD | 4.202% |
| Medical Imaging Corporation | 300.94 Million TWD | 70.631% |
| Healthconn Corp. | 622.48 Million TWD | 85.801% |
| iXensor Co., Ltd. | 63.64 Million TWD | -38.87% |
| Brighten Optix Corporation | 204.39 Million TWD | 56.759% |
| A-SPINE Asia Co., Ltd. | 240.61 Million TWD | 63.267% |
| Delta Asia International Corporation | 1.78 Billion TWD | 95.052% |
| Wiltrom Co., Ltd. | 126.69 Million TWD | 30.236% |
| Taiwan Advanced Nanotech Inc. | 597.53 Million TWD | 85.209% |
| Ever Fortune.AI Co., Ltd. | 88.03 Million TWD | -0.395% |
| Acer Medical Inc. | 37.49 Million TWD | -135.754% |
| Aplus Biotechnology Corporation Limited | 243.38 Million TWD | 63.685% |
| Qing Song Health Co.,Ltd. | 1.02 Billion TWD | 91.397% |
| MEM Dental Technology Co., Ltd. | 102.77 Million TWD | 14.003% |
| ShareHope Medicine Co., Ltd. | 3.49 Billion TWD | 97.468% |
| EBM Technologies Incorporated | 179.57 Million TWD | 50.781% |